Methamphetamine-induced neurotoxicity: the road to Parkinson's disease.

Journal Title: Pharmacological Reports - Year 2009, Vol 61, Issue 6

Abstract

Studies have implicated methamphetamine exposure as a contributor to the development of Parkinson's disease. There is a significant degree of striatal dopamine depletion produced by methamphetamine, which makes the toxin useful in the creation of an animal model of Parkinson's disease. Parkinson's disease is a progressive neurodegenerative disorder associated with selective degeneration of nigrostriatal dopaminergic neurons. The immediate need is to understand the substances that increase the risk for this debilitating disorder as well as these substances'neurodegenerative mechanisms. Currently, various approaches are being taken to develop a novel and cost-effective anti-Parkinson's drug with minimal adverse effects and the added benefit of a neuroprotective effect to facilitate and improve the care of patients with Parkinson's disease. Amethamphetamine-treated animal model for Parkinson's disease can help to further the understanding of the neurodegenerative processes that target the nigrostriatal system. Studies on widely used drugs of abuse, which are also dopaminergic toxicants, may aid in understanding the etiology, pathophysiology and progression of the disease process and increase awareness of the risks involved in such drug abuse. In addition, this review evaluates the possible neuroprotective mechanisms of certain drugs against methamphetamine-induced toxicity.

Authors and Affiliations

Bessy Thrash, Kariharan Thiruchelvan, Manuj Ahuja, Vishnu Suppiramaniam, Muralikrishnan Dhanasekaran

Keywords

Related Articles

Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice.

Background: Cytisine (CYT), the most commonly used drug for smoking cessation in Poland, was experimentally found to induce convulsions. There is a lack of studies on the influence of CYT on the anticonvulsant activity o...

Influence of short-term L-arginine supplementation on carbohydrate balance in rats with ischemia-reperfusion syndrome.

Background: There are studies showing stimulative effect of arginine on insulin secretion. This mechanism is not fully explained. The effects of the impact of arginine on carbohydrate balance under the conditions of isch...

Potential role of G protein-coupled receptor (GPCR) heterodimerization in neuropsychiatric disorders: a focus on depression.

G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins in the human genome and are the target of approximately half of all therapeutic drugs. For many years, GPCRs were thought to exist and...

Differential response of human healthy lymphoblastoid and CCRF-SB leukemia cells to sulforaphane and its two analogues: 2-oxohexyl isothiocyanate and alyssin.

The chemopreventive effect of sulforaphane and two of its analogues on human B-lymphocytes derived cells was evaluated in this study. Two cell lines used in the experiments were: human lymphoblastoid cells and human B-le...

Effect of clofibrate on vascular reactivity in a model of high blood pressure secondary to aortic coarctation.

The aims of this study were to identify the effect of clofibrate administration in the development of high blood pressure secondary to aortic coarctation (AoCo) and to assess its effect on vascular reactivity. Three expe...

Download PDF file
  • EP ID EP144689
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

Bessy Thrash, Kariharan Thiruchelvan, Manuj Ahuja, Vishnu Suppiramaniam, Muralikrishnan Dhanasekaran (2009). Methamphetamine-induced neurotoxicity: the road to Parkinson's disease.. Pharmacological Reports, 61(6), 966-977. https://europub.co.uk/articles/-A-144689